New drug combo tested for tough cancers

NCT ID NCT06537310

Ongoing Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This early-stage study tests an experimental drug called RO7567132, alone or with another drug (atezolizumab), in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. About 34 participants will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER-NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer metastatic malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER-NEOPLASMS

Contacts and locations

Locations

Austin Health

Heidelberg, Victoria, 3084, Australia
BC Cancer ? Vancouver

Vancouver, British Columbia, V5Z 4E6, Canada
Clinica Universidad de Navarra Madrid

Madrid, 28027, Spain
Fundacion Jimenez Diaz

Madrid, 28040, Spain
Kinghorn Cancer Centre

Darlinghurst, New South Wales, 2010, Australia
McGill University Health Center

Montreal, Quebec, H4A 3J1, Canada
Princess Margaret Cancer Center

Toronto, Ontario, M5G 2M9, Canada
Rigshospitalet

København Ø, 2100, Denmark
UZ Leuven Gasthuisberg

Leuven, 3000, Belgium
Vall d?Hebron Institute of Oncology (VHIO), Barcelona

Barcelona, 08035, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.